Transcripts NFL Biosciences

Stocks

Real-time Euronext Paris 06:04:10 2026-10-13 EDT			5-day change	1st Jan Change
0.6100 ^EUR	-1.61%		-6.73%	-48.22%

10-06	NFL Biosciences Provides Progress Update on NFL-101 and NFL-102 Clinical Programs in Smoking Cessation	CI
07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI

No results match your criteria